Skip to main content
Clinical Trials/JPRN-UMIN000031797
JPRN-UMIN000031797
Completed
未知

Transcatheter arterial micro-embolization (TAME) using imipenem/cilastatin sodium for chronic musculoskeletal pain chronic musculoskeletal pain resistant to conservative treatment - Clinical efficacy of TAME for chronic musculoskeletal pain

Wakayama medical university0 sites50 target enrollmentApril 1, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
lateral humeral epicondylitis, medial humeral epicondylitis, shoulder periarthritis, intractable pain after artificial joint surgery, knee osteoarthritis, hip osteoarthritis
Sponsor
Wakayama medical university
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2018
End Date
March 31, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Surgical candidate 2\)Patients with major depression 3\)Patients with uncontrollable diabetic mellitus 4\)Patients without possibility of going to hospital and follow up for 6 months. 5\)Patient who was decided not to be appropriate for this trial by physician 6\)Patients with a history of hypersensitivity or shock to antibiotics of imipenem . cilastatin, carbapenem, penicillin or cephem 7\)Patients who are receiving sodium valproate 8\)Patients with a history of severe thrombotic symptoms such as myocardial infarction and cerebral infarction 9\)Patients diagnosed as anti\-phospholipid antibody syndrome 10\)Patients performing antiplatelet drugs or anticoagulation therapy 11\)Patients diagnosed as collagen diseases such as rheumatoid arthritis and polymyalgia rheumatic 12\)Pregnant patient

Outcomes

Primary Outcomes

Not specified

Similar Trials